BioMed Research International

BioMed Research International / 2019 / Article

Research Article | Open Access

Volume 2019 |Article ID 3286489 | 10 pages |

Bioactivities of Flavonoids from Lopezia racemosa

Academic Editor: Gail B. Mahady
Received15 Nov 2018
Revised19 Feb 2019
Accepted20 Mar 2019
Published11 Apr 2019


Lopezia racemosa Cav. (Onagraceae) has been used in Mexican traditional medicine to alleviate stomachache, biliary colic, urine retention, stomach cancer, and skin, dental, buccal, and urinary infections. The objective of this study was to determine the bioactivities of specific parts of the plant to scientifically confirm its traditional use. Aerial parts and flowers were macerated and subsequently extracted with hexane, chloroform, and methanol. This study was focused on the analysis of polar components, and thus the methanolic fractions were selected for further investigations. These fractions were evaluated for their antimicrobial activity using a panel of bacterial Gram-positive and -negative strains, as well as fungal strains, including filamentous fungi and yeasts. In addition, the cytotoxic activity of the extract was assessed by MTT using the human-derived monocytic THP-1 and the normal human fibroblast cell lines. Various fractions showed antimicrobial activity against various pathogens, although the most relevant were against Pseudomonas aeruginosa and Trichophyton mentagrophytes. No inhibition of yeasts was recorded. Only four fractions showed cytotoxic effects when the human-derived THP-1 and fibroblast cells were assessed. The four flavonoids isolated from the extract were luteolin, luteolin-6-C-hexoside, luteolin-8-C-hexoside, and hyperoside. The biological activities presented in this study validate some traditional uses of the plant.

1. Introduction

The genus Lopezia (Onagraceae) consists of 45 species ( restricted to a large extent to Mexico [1]. The common names of Lopezia racemosa (synonym: L. mexicana) are “perilla”, “guayabilla”, “brad”, and “cancer weed” [2]. The leaves of L. racemosa are used as an infusion to reduce toothache [3], to relieve stomach and throat pain, against stomach cancer, against infections in the urinary tract, to wash skin infections with pus [4], and against diarrhea [5].

Studies of genus Lopezia are very scarce and only a previous study from our research group reported the antimicrobial activity of the chloroform and methanolic fractions from L. racemosa [6]. In that study, antibacterial and antifungal activities against a panel of strains were reported. Also, the cytotoxic activities of the hexane, chloroform, and methanol extracts against THP-1 cells were reported with of 31 μg/mL, 29 μg/mL, and 30 μg/mL, respectively [6].

Another study reported the production of the anti-inflammatory compound 6-O-palmitoyl-3-O-β-D-glucopyranosylcampesterol using a callus culture of the same plant [7].

Following our research program of studying Mexican plants used in traditional medicine, we investigated the methanol extract and its fractions from the aerial parts of L. racemosa to evaluate the antimicrobial, antifungal, and cytotoxic activities. The phytochemistry of the fractions was also studied and the identified compounds were flavonoids.

2. Material and Methods

2.1. Chemicals

The following reagents were used: hexane, chloroform, methanol, and acetone from RBM (Puebla, Mexico); dimethyl sulfoxide (DMSO), formamide (FA), HPLC-grade methanol, H3PO4, HCl, AlCl3, Na acetate, H3BO3 were purchased from Sigma-Aldrich.

2.2. Strains and Culture Media

The Gram-negative strains used in this study were Acinetobacter baumannii (ATCC BAA-747), Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 14210), and Salmonella typhimurium (ATCC 13311). The Gram-positive strains were Bacillus subtilis (ATCC 6633), Staphylococcus aureus (ATCC 25923), methicillin-resistant Staphylococcus aureus (MRSA) (ATCC 700698), and Streptococcus pyogenes (ATCC 51878). The filamentous fungi included Aspergillus fumigatus (ATCC 1022) and Trichophyton mentagrophytes (ATCC 9533), whereas Candida albicans (ATCC 10231) and Cryptococcus neoformans var. grubii (provided by Dr. Karen Bartlett, University of British Columbia, BC, Canada) represented pathogenic fungi. Bacterial strains were cultured at 37°C in Mueller-Hinton broth (B&D), whereas fungal strains were cultured at 28°C using Sabouraud broth (B&D).

2.3. Plant Material and Extract Preparation

L. racemosa was collected in San Francisco Papalotla, Tlaxcala, Mexico, at 2,000 m above sea level (19°10’02.2’’N, 98°11’37.1’’W). A voucher specimen numbered 59890 was deposited in the Herbarium of the Benemérita Universidad Autónoma de Puebla, México. The plant was identified by the Lic. Allen James Coombes.

500 g of dried leaves was successively macerated with 5 L of hexane, 6.5 L of chloroform, and 7.5 L of methanol for 24 h under stirring, obtaining 13.2 g (2.64%), 11.72 g (2.34%), and 53.21 g (10.64%) of extract, respectively. The solvents were evaporated under reduced pressure to dryness using a rotary evaporator (Büchi, Switzerland). A column packed with Diaion HP-20 (60 cm x 10 cm) (Mitsubishi Chemical Corp., Japan) was used to apply 20 g of the methanol extract. Compounds were eluted with a water-methanol polarity gradient from 100:0 to 0:100 and the separation was monitored by UV spectroscopy.

A similar protocol was followed for compound extraction using collected flowers, but using a total of 50 g of dried flowers and 500 mL of each solvent.

2.4. HPLC Purification

The separation of the compounds was performed with an HPLC instrument (Agilent 1200) equipped with a photodiode array detector (G1315B), an autosampler (G1329B), and Agilent Chemstation software. Chromatographic separation was performed using an Econosil C18 column (250 x 10 mm, particle size 10 μm, Alltech). A solvent gradient was run starting from 60:40 methanol-H3PO4 (50 mM) during 10 min and then 50:50 methanol-H3PO4 (50 mM) for 15 min, 90:10 methanol-H3PO4 (50 mM) for 25 min, and finally 100% methanol for 30 min. The separation was performed at room temperature (24°C) and the flow rate was 1 mL/min. The injection volume was 100 μL and the total run time was 60 min. The detection of compounds was made at 240, 250, 260, 270, 280, 290, 300, and 360 nm. Samples were prepared by dissolving 5 mg of the fraction in 100 μL of the appropriate solvent (MeOH, DMSO or FA). Compounds 1, 2, and 3 were isolated from fractions 216 – 229 (eluted using 30% water), 274 – 278, and 279 – 293 (both eluted using 20% water) with amounts < 0.7 mg, respectively. Compound 4 (1.1 mg) was isolated from fractions 744 – 749.

2.5. Chemical Structure Assignment

The mass fragmentations of the isolated compounds were determined by fast atom bombardment (FAB) and electrospray ionization (ESI). In the case of FAB, a JEOL instrument equipped with JMS-700D Mstation was used. The running was performed using a FAB+ mode with Xe (ionizing gas), an ionization temperature of 29°C, an energy of 6 keV, and an emission current of 6 mA.

Regarding the ESI experiment, an Advion Expression S CMS was used with as the ionizing gas and direct injection of the sample. The instrument was run in negative and positive polarities. In the case of the negative polarity, the capillary temperature was at 200°C and the capillary voltage was 180 V with a voltage source of 30 V. The ESI source used a gas temperature of 250°C and a voltage of 2,500 V. The positive polarity used a capillary temperature of 250°C, a capillary voltage of 180°C, and a voltage source of 20 V. The ESI source used a gas temperature of 250°C and a voltage of 3,150 V.

The identification of the compounds was performed by UV spectroscopy (UV-VIS Varian Cary-1) using quartz cuvettes and according to published methodology [8]. The compound identification was performed according to displacement reagents and comparison to published spectra [8]. NMR experiments were performed in a Bruker Avance III 400 MHZ equipment.

2.6. Biological Assays

Because of the high polarity of the isolated compounds, DMSO and FA were used as the dissolving agents. As a result of the toxicity of both solvents, the final concentration in the culture of bacteria and fungi was 1% and 5% for FA and DMSO, respectively. When the THP-1 and fibroblast cell lines were assessed, the final concentration of DMSO in the culture was 1%. Fractions dissolved in FA were not assessed as the final concentration of FA in the culture >0.1% was lethal for the cells.

2.6.1. Antibacterial Assay (MIC)

The antibacterial assay was performed as published [6]. Briefly, in a 96-well plate, a mixture of compound and inoculum in 100 μL Mueller-Hinton broth was dispensed. Samples were tested in the following concentrations: 25, 50, 100, 125, 250, and 500 μg/mL. The inoculum was prepared to have a final optical density of 0.05 . The mixtures were incubated in a shaker at 37°C for 18 h. The MIC was determined as the concentration of the compound at which no bacterial growth was observed.

2.6.2. Antifungal Assay

The antifungal assay was very similar to the antibacterial assay with some minor modifications. Fungal strains were cultured in Sabouraud broth at 30°C for 24-48 h or until the untreated control showed growth. The yeast inoculum was prepared as in the previous section, while the filamentous fungi were grown from spores as published [9].

2.6.3. Cytotoxicity

The analysis of the cytotoxicity of the compounds was performed using the human-derived monocytic THP-1 (ATCC TIB-202) and normal fibroblast (PromoCell, C-12352) cell lines. The assay was performed as previously published [6]. Both cell lines were treated with the compounds and untreated cells and DMSO were used as negative control, whereas 2% Tween-20 was used as a positive control. The cytotoxicity was determined by the MTT assay [10]. The fractions were tested at a final concentration of 20 μg/mL (DMSO<1%).

2.7. Statistical Analysis

A Student’s t-test was used to assess the significance of the cytotoxicity. Experiments were performed in triplicate.

3. Results

A total of 961 and 465 fractions were obtained from the methanol extracts of leaves and flowers, respectively. These fractions were subsequently grouped in 117 and 85 fractions according to their UV profile, respectively.

The methanol extract was mainly composed of a complex mixture of tannins and flavonoids, which were difficult to purify. Therefore, a few fractions with the highest content of compounds were used to separate and identify the proposed structures, which were based on the UV-Vis behavior using displacement reagents and verified according to published spectra [8].

3.1. Chemical Structure Assignment

The methanolic fraction 216-229 from leaves showed a characteristic UV spectrum of a flavone because of the maximal absorption of the band I at 352 nm. In addition, the band II showed two maximal absorptions at 266 (band IIa) and 256 nm (band IIb), indicating the presence of two hydroxyl groups at positions 3’ and 4’ [8]. A chemical shift was observed when NaOMe was added, which produced a bathochromic shift of 52 nm in the band I without decrease of the intensity or the breakdown of the molecule after 5 min after addition, confirming the presence of a 4’-OH group and absence of the 3-OH group. In addition, a bathochromic shift of 16 nm was observed in band II after the addition of NaOAc, which indicated the presence of the 7-OH group after the stability of the molecule was confirmed. Sequential addition of H3BO3 to the same reaction caused a bathochromic shift of 19 nm in the band I, confirming the presence of an ortho-dihydroxylic system in the ring B. Moreover, the addition of AlCl3 caused a bathochromic shift of 72 nm in the band I, with a posterior hypsochromic shift of 25 nm after the addition of HCl. These changes in the bands confirmed again the presence of an ortho-dihydroxylic system in ring B together with the presence of the 5-OH group.

After a comparison of the spectra obtained (Figure 1) with the spectra published by Mabry [8], we conclude that the compound 1 has the luteolin-6-C-hexoside structure, with spectra comparable to the compound isoorientin. Following the same procedure, the flavonoids present in the fractions 274 – 278 and 279 – 293 were luteolin (2) and luteolin-8-C-hexoside (3), respectively, showing comparable spectra to luteolin (Figure 2) and orientin (Figure 3), respectively. We were not able to identify the sugar moiety in compounds 1 and 3 because of the very low amount isolated of these compounds.

The mass spectra of compound 4 showed the molecular ions [M+H]+ m/z 465 using FAB+ and [M+Na]+ m/z 487 and [M+K]+ m/z 503, using ESI+. A peak at m/z 303 (by FAB+) corresponding to the protonated quercetin aglycone was also identified by ESI+. Further analysis of the results showed that the ion [M+Na]+ m/z 487 showed a base peak at m/z 307, which corresponds to the fragment [quercetin+Na-H2O]+ (Figure 4(a)). These data concord with the displacement shifts observed in the UV spectra following the techniques previously described (Figure 4(b)). Thus, based on all of the analysis described, it can be deduced that the structure of compound 4 corresponds to quercetin-3-O-hexoside. NMR experiments confirmed the above findings showing signals in both 1H and 13C spectra corresponding to the aglycone quercetin. Spectra also showed a glycoside moiety linked to C-3 of the aglycone, which was deduced from the HMBC experiment. The sugar moiety was identified as a galactoside from its 13C NMR spectrum. Hence, compound 4 was identified as hyperoside, which was further confirmed by comparing its spectral data with those published in the literature [11].

The fractions obtained from the flower extract showed two types of UV profiles. The first type suggested the presence of tannins in the first fractions, whereas a flavonoid was observed in the last fractions (Figure 5). The IR spectrum of the fraction 22 – 26 was similar to the IR spectrum of the tannic acid (Figure 6), suggesting that this compound can be present in this fraction.

3.2. Antimicrobial Assays

Analysis of the different fractions against a panel of bacteria and fungi showed antimicrobial activity against Gram-positive, Gram-negative, and filamentous fungal strains (Table 1). Although most of the fractions gave a relative weak antimicrobial activity (range: 250-500 μg/mL) only the leaf fractions 447-506 (TM=125 μg/mL), 852-856 (PA=50 μg/mL) as well as the flower fraction 304-310 (PA=100 μg/mL) showed antimicrobial activity in the range of potential discovery of pure antimicrobial agents (~100 μg/mL).



AB, Acinetobacter baumannii; BS, Bacillus subtilis; EC, Escherichia coli; EF, Enterococcus faecalis; MRSA, methicillin-resistant Staphylococcus aureus; MS, Mycobacterium smegmatis; PA, Pseudomonas aeruginosa; SA, Staphylococcus aureus; AF, Aspergillus fumigatus; CA, Candida albicans; CN, Cryptococcus neoformans; TR, Trichophyton mentagrophytes. R, resistant. Amikacin, Gentamicin, Rifampicin, Amphotericin B, Terbinafine. Experiments were performed in triplicate.
3.3. Cytotoxicity

Analysis of the cytotoxicity of the fractions showed that most of them were innocuous for both cell lines except the fractions 905-915, 916-924, and 925-941 (Figure 7).

4. Discussion

The plant L. racemosa is used in the Mexican traditional medicine to treat different diseases, including infections associated with the skin and the urinary system.

In this study, the methanolic extract from leaves and flowers as well as their fractions was assessed for their antimicrobial activities against a panel of Gram-positive, Gram-negative, and fungal pathogenic strains. Analysis of the results showed antibacterial and antifungal activities of 50-500 μg/mL and 125-500 μg/mL, respectively (Table 1) with the strongest activity observed against P. aeruginosa and T. mentagrophytes. Similar results regarding the antibacterial activity with MICs ranging between 40 and 400 μg/mL were reported in a previous study from our lab [6]. However, the fungal pathogen Trichophyton rubrum was inhibited when a concentration of 40 μg/mL was used, whereas we report here a MIC of 125 μg/mL. The discrepancies in the antimicrobial activities can be attributed to the fact that a different method of purification was used in the present study.

As mentioned earlier, reports about the antimicrobial activity of the genus Lopezia are rare and thus our results cannot be compared to the literature.

Results of our studies addressed the control of important pathogens such as P. aeruginosa, which is a known pathogen causing skin and urinary infections, including complications in burnt skin [1214]. These infections can be aggravated by the establishment of biofilms [15, 16] with difficulties to eradicate the pathogen.

Another pathogen controlled by the fractions of the plants was T. mentagrophytes responsible for skin infections and cutaneous mycosis, including tinea capitis (head), tinea corporis (body), and tinea pedis (foot) [17, 18].

Other skin-related pathogens to which a weak antibacterial activity was measured were S. aureus, MRSA, and S. epidermidis (Table 1), all of them causing skin infections [1922], and tonsils, retropharyngeal, and parapharyngeal abscesses [2325].

A phytochemical analysis of some of the fractions identified the four flavonoids luteolin, luteolin-6-C-hexoside, luteolin-8-C-hexoside, and hyperoside.

In the case of luteolin, antibacterial activities against P. aeruginosa, S. aureus, streptococcal strains, and Phorphyromonas gingivalis with MICs > 100 μg/mL were reported [26, 27]. Other studies reported antibacterial activities against P. aeruginosa (MICs = 200-625 μg/mL), S. aureus (MIC = 15 μg/mL), and S. enterica serovar Thyphimurium (S. Thyphimurium, MIC = 20 μg/mL) [28, 29]. The discrepancies between these values can be related either to the purity of the compound or to the strains used to assess the antimicrobial activity.

In the present study, we were not able to identify the sugar group attached to the flavonoids 1 and 3 as a result of the very low amount obtained from the isolated compound, except for hyperoside. Frequently, the identification of the sugar moiety is not provided and thus defined as pentoside or hexoside as published [3032]. Therefore, we discuss the alternative optional names when the monosaccharide of luteolin-6-C-hexoside and luteolin-8-C-hexoside is glucose and then defined as isoorientin and orientin, respectively. In addition, when quercetin-3-O-hexoside contains a glucose unit it is defined as isoquercitrin, a rhamnose unit defines it as quercitrin, and finally, the presence of a galactose unit is defined as hyperoside.

In the case of isoorientin, studies have reported MICs ranging between 100 and 1000 μg/mL for P. aeruginosa and S. aureus, respectively [26, 28]. In the case of orientin, similar antibacterial activity was reported against P. aeruginosa and S. aureus as compared to isoorientin [26]. When the antifungal activity was tested against a panel of fungal pathogens, strong antifungal activity was reported against T. mentagrophytes (MIC=8 μg/mL) [33].

Analysis of the bioactivities of isoquercitrin and quercitrin showed that both had similar antibacterial activity against a panel of bacterial phytopathogens and S. aureus expressed as zone of inhibition [34]. On the other hand, quercitrin has been reported to inhibit the growth of S. epidermidis, an important pathogen in periodontal diseases [35].

A similar structure of luteolin-8-C-hexoside defined as luteolin-7-O-glucoside was reported for its antibacterial activities against S. thyphimurium, P. aeruginosa, and S. aureus. In that report, the antibacterial activity was reported as the zone of inhibition of the compound that could not be comparable to our MIC [36]. It is noteworthy to mention that the difference between the sugar binding to the core molecule in luteolin-7-O-glucoside is through oxygen bound (easily hydrolyzable), whereas, in our identified compound luteolin-8-C-hexoside, the binding is through a carbon, a nonhydrolysable molecule.

Lastly, antifungal activities have been reported when hyperoside was tested against a panel of fungal and bacterial phytopathogens. For example, fungal strains from the genera Alternaria, Epicoccum, Pestalotia, Drechslera, and Fusarium were inhibited by hyperoside at concentrations ranging from 50 to 150 μg/mL [37].

Hyperoside has shown a weak antibacterial activity against E. coli and S. aureus with zone of inhibitions ranging between 0.4 and 0.9 mm [34].

Finally, the cytotoxic assessment performed in the current report showed that most of the methanolic fractions were not toxic to both macrophages and fibroblast cell lines used in this study. Another study reported that the crude extract from genetically modified hairy roots from L. racemosa were toxic to a panel of cell lines, including the cell lines HCT-15 (colon adenocarcinoma), Ovcar (ovarian cancer), and KB (laryngeal cancer) [38]. The main difference in the cytotoxicity when comparing to our study can be related to the different cell lines used in our study and also to the fact that we used wild plants, whereas Moreno-Anzurez’ study used a genetically modified roots.

In conclusion, we report here that the methanolic fractions isolated from the leaves and flowers of L. racemosa showed antibacterial and antifungal activities, supporting its use in traditional medicine.


ATCC:American type culture collection
DMSO:Dimethyl sulfoxide
ESI:Electrospray ionization
FAB:Fast atom bombardment
HPLC:High performance liquid chromatography
MIC:Minimum inhibitory concentration
MRSA:Methicillin-resistant Staphylococcus aureus
MTT:3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
NaOAc:Sodium acetate
NaOMe:Sodium methoxide
NMR:Nuclear Magnetic Resonance
PA: Pseudomonas aeruginosa
TM: Trichophyton mentagrophytes

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare that they have no conflicts of interest.


Enrique Vergara Barragán thanks CONACyT for a doctoral fellowship. We also thank Hagar Bach and Marilyn Robertson for helpful discussions.

Supplementary Materials

13C NMR analysis of compound 4 (hyperoside). (Supplementary Materials)


  1. P. C. Hoch, J. V. Crisci, and H. Tobe, “A cladistic analysis of the genus Lopezia (onagraceae),” Botanical Journal of the Linnean Society, vol. 111, no. 2, pp. 103–116, 1993. View at: Publisher Site | Google Scholar
  2. M. D. Barba-Avila, M. C. Hernández-Duque, and M. Cerda-Lemus, Plantas útiles de la región semiárida de Aguascalientes, Universidad Autonoma de Aguascalientes, Aguascalientes, Mexico, 2003.
  3. National Institute of Ecology and Climate Change,
  4. Biblioteca Digital de la Medicina Tradicional Mexicana, “Atlas de las plantas de la medicina tradicional mexicana,” View at: Google Scholar
  5. M. M. Ávila-Uribe, S. N. García-Zárate, A. S. Sepúlveda-Barrera et al., “Plantas medicinales en dos poblados del municipio de San Martín de las Pirámides, Estado de México,” Polibotánica, no. 42, pp. 215–245, 2016. View at: Google Scholar
  6. C. C. Paredes, P. B. Balbás, A. Gómez-Velasco et al., “Antimicrobial, antiparasitic, anti-inflammatory, and cytotoxic activities of Lopezia racemosa,” The Scientific World Journal, vol. 2013, Article ID 237438, 6 pages, 2013. View at: Publisher Site | Google Scholar
  7. R. Salinas, J. Arellano-García, I. Perea-Arango et al., “Production of the anti-inflammatory compound 6-o-palmitoyl-3-O-β-D- glucopyranosylcampesterol by callus cultures of lopezia racemosa cav. (onagraceae),” Molecules, vol. 19, no. 6, pp. 8679–8690, 2014. View at: Publisher Site | Google Scholar
  8. T. J. Mabry, K. R. Markham, and M. B. Thomas, The Systematic Identification of Flavonoids, Springer Berlin Heidelberg, Berlin, Germany, 1970. View at: Publisher Site
  9. A. V. Contreras Cárdenas, L. R. Hernández, Z. N. Juárez, E. Sánchez-Arreola, and H. Bach, “Antimicrobial, cytotoxic, and anti-inflammatory activities of Pleopeltis polylepis,” Journal of Ethnopharmacology, vol. 194, pp. 981–986, 2016. View at: Publisher Site | Google Scholar
  10. Z. N. Juárez, L. R. Hernández, H. Bach, E. Sánchez-Arreola, and H. Bach, “Antifungal activity of essential oils extracted from Agastache mexicana ssp. xolocotziana and Porophyllum linaria against post-harvest pathogens,” Industrial Crops and Products, vol. 74, pp. 178–182, 2015. View at: Publisher Site | Google Scholar
  11. M. Sikorska and I. Matlawska, “Quercetin and its glycosides in the flowers of Asclepias syriaca L,” Acta Poloniae Pharmaceutica. Drug Research, vol. 57, no. 4, pp. 321–324, 2000. View at: Google Scholar
  12. J. P. Lynch, G. G. Zhanel, and N. M. Clark, “Emergence of antimicrobial resistance among pseudomonas aeruginosa : implications for therapy,” Seminars in Respiratory and Critical Care Medicine, vol. 38, no. 3, pp. 326–345, 2017. View at: Publisher Site | Google Scholar
  13. R. Mittal, S. Aggarwal, S. Sharma, S. Chhibber, and K. Harjai, “Urinary tract infections caused by Pseudomonas aeruginosa: a minireview,” Journal of Infection and Public Health, vol. 2, no. 3, pp. 101–111, 2009. View at: Publisher Site | Google Scholar
  14. R. Serra, R. Grande, L. Butrico et al., “Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus,” Expert Review of Anti-infective Therapy, vol. 13, no. 5, pp. 605–613, 2015. View at: Publisher Site | Google Scholar
  15. J. W. Newman, R. V. Floyd, and J. L. Fothergill, “The contribution of Pseudomonas aeruginosa virulence factors and host factors in the establishment of urinary tract infections,” FEMS Microbiology Letters, vol. 364, no. 15, 2017. View at: Publisher Site | Google Scholar
  16. R. Sopeña-Sutil, J. Medina-Polo, J. Justo-Quintas et al., “Healthcare-associated infections after lower urinary tract endoscopic surgery: analysis of risk factors, associated microorganisms and patterns of antibiotic resistance,” Urologia Internationalis, vol. 100, no. 4, pp. 440–444, 2018. View at: Publisher Site | Google Scholar
  17. A. Gupta, R. Mays, S. Versteeg et al., “Tinea capitis in children: a systematic review of management,” Journal of the European Academy of Dermatology and Venereology, vol. 32, no. 12, pp. 2264–2274, 2018. View at: Publisher Site | Google Scholar
  18. H. Su, L. Li, B. Cheng et al., “Trichophyton rubrum Infection Characterized by Majocchi’s Granuloma and Deeper Dermatophytosis: Case Report and Review of Published Literature,” Mycopathologia, vol. 182, no. 5-6, pp. 549–554, 2017. View at: Publisher Site | Google Scholar
  19. S. Kleinschmidt, F. Huygens, J. Faoagali, I. U. Rathnayake, and L. M. Hafner, “Staphylococcus epidermidis as a cause of bacteremia,” Future Microbiology, vol. 10, no. 11, pp. 1859–1879, 2015. View at: Publisher Site | Google Scholar
  20. K. Loewen, Y. Schreiber, M. Kirlew, N. Bocking, and L. Kelly, “Community-associated methicillin-resistant Staphylococcus aureus infection: Literature review and clinical update,” Canadian Family Physician, vol. 63, no. 7, pp. 512–520, 2017. View at: Google Scholar
  21. N. E. Natsis and P. R. Cohen, “Coagulase-negative staphylococcus skin and soft tissue infections,” American Journal of Clinical Dermatology, vol. 19, no. 5, pp. 671–677, 2018. View at: Publisher Site | Google Scholar
  22. P. Y. Ong and D. Y. M. Leung, “Bacterial and viral infections in atopic dermatitis: a comprehensive review,” Clinical Reviews in Allergy and Immunology, vol. 51, no. 3, pp. 329–337, 2016. View at: Google Scholar
  23. I. Brook, “Microbiology and management of peritonsillar, retropharyngeal, and parapharyngeal abscesses,” Journal of Oral and Maxillofacial Surgery, vol. 62, no. 12, pp. 1545–1550, 2004. View at: Publisher Site | Google Scholar
  24. I. Brook and P. A. Foote, “Isolation of methicillin resistant Staphylococcus aureus from the surface and core of tonsils in children,” International Journal of Pediatric Otorhinolaryngology, vol. 70, no. 12, pp. 2099–2102, 2006. View at: Publisher Site | Google Scholar
  25. R. Lindroos, “Bacteriology of the tonsil core in recurrent tonsillitis and tonsillar hyperplasia - a short review,” Acta Otolaryngologica, vol. 543, pp. 206–208, 2000. View at: Google Scholar
  26. F. Cottiglia, G. Loy, D. Garau et al., “Antimicrobial evaluation of coumarins and flavonoids from the stems of Daphne gnidium L.,” Phytomedicine, vol. 8, no. 4, pp. 302–305, 2001. View at: Publisher Site | Google Scholar
  27. H. Yamamoto and T. Ogawa, “Antimicrobial activity of perilla seed polyphenols against oral pathogenic bacteria,” Bioscience, Biotechnology, and Biochemistry, vol. 66, no. 4, pp. 921–924, 2002. View at: Publisher Site | Google Scholar
  28. F. U. Afifi and R. Abu-Dahab, “Phytochemical screening and biological activities of Eminium spiculatum (Blume) Kuntze (family Araceae),” Natural Product Research, vol. 26, no. 9, pp. 878–882, 2012. View at: Publisher Site | Google Scholar
  29. K. Rashed, A. Ćirić, J. Glamočlija, and M. Soković, “Antibacterial and antifungal activities of methanol extract and phenolic compounds from Diospyros virginiana L.,” Industrial Crops and Products, vol. 59, pp. 210–215, 2014. View at: Publisher Site | Google Scholar
  30. H. Çelik and M. Koşar, “Inhibitory effects of dietary flavonoids on purified hepatic NADH-cytochrome b5 reductase: structure-activity relationships,” Chemico-Biological Interactions, vol. 197, no. 2, pp. 103–109, 2012. View at: Publisher Site | Google Scholar
  31. J. Cheel, C. Theoduloz, J. A. Rodríguez, P. D. S. Caligari, and G. Schmeda-Hirschmann, “Free radical scavenging activity and phenolic content in achenes and thalamus from Fragaria chiloensis ssp. , F. vesca and F. x ananassa cv. Chandler,” Food Chemistry, vol. 102, no. 1, pp. 36–44, 2007. View at: Publisher Site | Google Scholar
  32. S. Galasso, S. Pacifico, N. Kretschmer et al., “Influence of seasonal variation on Thymus longicaulis C. Presl chemical composition and its antioxidant and anti-inflammatory properties,” Phytochemistry, vol. 107, pp. 80–90, 2014. View at: Publisher Site | Google Scholar
  33. M. P. De Campos, V. Cechinel Filho, R. Z. Da Silva et al., “Evaluation of antifungal activity of Piper solmsianum C. DC. var. solmsianum (Piperaceae),” Biological & Pharmaceutical Bulletin, vol. 28, no. 8, pp. 1527–1530, 2005. View at: Publisher Site | Google Scholar
  34. J. R. Soberón, M. A. Sgariglia, M. R. Dip Maderuelo, M. L. Andina, D. A. Sampietro, and M. A. Vattuone, “Antibacterial activities of Ligaria cuneifolia and Jodina rhombifolia leaf extracts against phytopathogenic and clinical bacteria,” Journal of Bioscience and Bioengineering, vol. 118, no. 5, pp. 599–605, 2014. View at: Publisher Site | Google Scholar
  35. M. Gómez-Florit, M. Monjo, and J. M. Ramis, “Identification of quercitrin as a potential therapeutic agent for periodontal applications,” Journal of Periodontology, vol. 85, no. 7, pp. 966–974, 2014. View at: Publisher Site | Google Scholar
  36. K. K. Chiruvella, A. Mohammed, G. Dampuri, R. G. Ghanta, and S. C. Raghavan, “Phytochemical and antimicrobial studies of methyl angolensate and luteolin-7-O-glucoside isolated from callus cultures of Soymida febrifuga,” International Journal of Biomedical Sciences, vol. 3, no. 4, pp. 269–278, 2007. View at: Google Scholar
  37. S. Li, Z. Zhang, A. Cain, B. Wang, M. Long, and J. Taylor, “Antifungal activity of camptothecin, trifolin, and hyperoside isolated from Camptotheca acuminata,” Journal of Agricultural and Food Chemistry, vol. 53, no. 1, pp. 32–37, 2005. View at: Publisher Site | Google Scholar
  38. N. E. Moreno-Anzúrez, S. Marquina, L. Alvarez et al., “A cytotoxic and anti-inflammatory campesterol derivative from genetically transformed hairy roots of Lopezia racemosa Cav. (Onagraceae),” Molecules, vol. 22, no. 1, p. 118, 2017. View at: Google Scholar

Copyright © 2019 Enrique Vergara Barragán et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

803 Views | 345 Downloads | 1 Citation
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.